Skip to main content
Signal8

Raffin Thomas A.

SEC insider (Form 3/4/5 filer). CIK 0001512119. Director at Akoya Biosciences, Inc. (AKYA) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on Jul 8, 2025. Located in AUSTIN, TN.

Companies Raffin Thomas A. has filed insider reports for

  • Akoya Biosciences, Inc. (AKYA): Director
  • LUMOS PHARMA, INC. ((LUMO)): Director
Raffin Thomas A. profile photo

Raffin Thomas A.

CIK: 0001512119

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)4 (100.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Akoya Biosciences, Inc. logo
AKYA

Akoya Biosciences, Inc.

Director
LUMOS PHARMA, INC. logo
(LUMO)

LUMOS PHARMA, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • Akoya Biosciences, Inc. logo
    AKYA

    Akoya Biosciences, Inc.

    Jul 8, 2025
    Other
    Indirect
    234.6K shares-
  • Akoya Biosciences, Inc. logo
    AKYA

    Akoya Biosciences, Inc.

    Jul 8, 2025
    Other
    Indirect
    1.7M shares-
  • Akoya Biosciences, Inc. logo
    AKYA

    Akoya Biosciences, Inc.

    Jul 8, 2025
    Other
    Indirect
    15.9M shares-
  • LUMOS PHARMA, INC. logo
    (LUMO)

    LUMOS PHARMA, INC.

    Dec 12, 2024
    Disposition
    Direct
    9.4K shares-

1-4 of 4